Sandra Steffens
Overview
Explore the profile of Sandra Steffens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
611
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Schroder D, Heinemann S, Heesen G, Klawonn F, Mikuteit M, Niewolik J, et al.
Eur J Med Res
. 2022 Jun;
27(1):97.
PMID: 35733228
Background: The influence of immunosuppressive therapy on immunogenicity after COVID-19 vaccination remains unclear. This study surveys patients who receive immunosuppressive therapy about whether or not they paused their immunosuppressive medication...
22.
Mondorf Y, Mikuteit M, Ivanyi P, Stohr C, Herrmann E, Polifka I, et al.
Urol Int
. 2022 Jun;
106(11):1168-1176.
PMID: 35654002
Introduction: Programmed death-1 ligand (PD-L1) has been often studied in different types of renal-cell carcinoma (RCC). For example, in clear-cell renal carcinoma it is well established that programmed death-1 receptor...
23.
Niewolik J, Mikuteit M, Cossmann A, Vahldiek K, Gutzmer R, Muller F, et al.
Oncology
. 2022 May;
100(7):392-398.
PMID: 35609553
Background: Immunogenicity of SARS-CoV-2 vaccines is modestly impaired in cancer patients due to a generally weakened immune system. Immune checkpoint inhibitors (ICI) are expected to enhance immune response. This has...
24.
Schroder D, Heesen G, Heinemann S, Hummers E, Jablonka A, Steffens S, et al.
Front Public Health
. 2022 May;
10:831087.
PMID: 35558532
Background: Restrictions to contain the COVID-19 pandemic affect the social participation of people worldwide. Especially those at high risk for a severe disease tend to abstain from social gatherings. While...
25.
Degen C, Mikuteit M, Niewolik J, Schroder D, Vahldiek K, Mucke U, et al.
Front Neurol
. 2022 May;
13:884002.
PMID: 35547372
Tinnitus, vertigo and dizziness are symptoms commonly reported among Long and Post COVID patients, however the severity of these symptoms has not been assessed in large trials. Therefore, in this...
26.
Muller F, Heinemann S, Hummers E, Noack E, Heesen G, Dopfer-Jablonka A, et al.
Z Rheumatol
. 2022 May;
82(4):342-354.
PMID: 35523964
Background: Immunocompromised people are less likely to be vaccinated, despite an increased benefit of many vaccinations in terms of benefit-risk assessment, including the vaccines against SARS CoV-2 (COVID-19). Attitudes, expectations,...
27.
Dopfer-Jablonka A, Steffens S, Muller F, Mikuteit M, Niewolik J, Cossmann A, et al.
BMC Infect Dis
. 2022 Apr;
22(1):403.
PMID: 35468758
Background: Immunocompromised people (ICP) and elderly individuals (older than 80 years) are at increased risk for severe coronavirus infections. To protect against serious infection with SARS-CoV-2, ICP are taking precautions...
28.
Zschabitz S, Erlmeier F, Stohr C, Herrmann E, Polifka I, Agaimy A, et al.
J Cancer
. 2022 Apr;
13(6):1706-1712.
PMID: 35399715
Prostate specific membrane antigen (PSMA) is an emerging diagnostic and therapeutic target in prostate cancer. Ga-PSMA-labeled hybrid imaging is used for the detection of prostate primary tumors and metastases. Therapeutic...
29.
Mikuteit M, Zschabitz S, Stohr C, Herrmann E, Polifka I, Agaimy A, et al.
Pathol Res Pract
. 2022 Feb;
231:153802.
PMID: 35180650
Background: Claudins are promising biomarkers for diagnosis and prognosis or targets for treatment. They play a major role in signal transduction and are important in nearly all aspects of tumorigenesis....
30.
Mikuteit M, Steffens S, Zschabitz S, Autenrieth M, Weichert W, Hartmann A, et al.
Oncology
. 2022 Feb;
100(6):331-336.
PMID: 35168242
Background: Overexpression of tumor-associated calcium signal transducer 2 (Trop2) is found in many tumor entities. The prognostic value of Trop2 in renal cell renal carcinoma (RCC), especially in nonclear cell...